Skip Navigation
Skip to contents

대한내분비학회

전체메뉴

대한내분비학회 내분비질환 관련 임상 및 기초 연구자들의 학술 활동의 구심점 역할을 충실히 수행합니다.

내분비 회원 저널 소개

Home > 학회지&간행물 > 내분비 소식지
  • 글자를 크게
  • 글자를 작게
  • 현재 페이지 프린트하기
학회지&간행물
게시판 검색 ~
번호 카테고리 EnM 인용 제목 저자 저널명 출판년도/월
1322 당뇨병/비만/지질 Change in body mass index and insulin resistance after 1-year treatment with gonadotropin-releasing hormone agonists in girls with central precocious puberty.22(1):27-35 Kim Jae Hyun Ann Pediatr Endocrinol Metab 2017/03
1321 당뇨병/비만/지질 Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.7:45425 Choi Han Seok Sci Rep 2017/03
1320 당뇨병/비만/지질 Impact of High-Carbohydrate Diet on Metabolic Parameters in Patients with Type 2 Diabetes.9(4) Chan-Hee Jung, Choi Kyung-Mook Nutrients 2017/03
1319 당뇨병/비만/지질 Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis.12(4):e0174717 Choi Kyung-Mook, Dong Seop Choi, Kim Nan-Hee, Sei Hyun Baik, Yoo Hye Jin PLoS One 2017/03
1318 당뇨병/비만/지질 Acute Hyperglycemia Associated with Anti-Cancer Medication.32(1):23-29 Eun Kyung Lee, Yul Hwangbo Endocrinol Metab (Seoul) 2017/03
1317 골대사 Comparison of bone mineral loss by combined androgen block agonist versus GnRH in patients with prostate cancer: A 12 month-prospective observational study. 7:39562 Sohee Kim Sci Rep 2017/03
1316 골대사 Lower Jump Power Rather Than Muscle Mass Itself is Associated with Vertebral Fracture in Community-Dwelling Elderly Korean Women. Kim Kyoung Min, Lee Eun Young, Seo, Da Hea, Su Jin Lee, Yumie Rhee Calcif Tissue Int 2017/03
1315 골대사 Alternative new mesenchymal stem cell source exerts tumor tropism through ALCAM and N-cadherin via regulation of microRNA-192 and -218. 427(1-2):177-185 Min-Young Lee Mol Cell Biochem 2017/03

상단으로 이동

Copyright ⓒ The Korean Endocrine Society. All rights Reserved

  • [04146] 서울특별시 마포구 마포대로 109 롯데캐슬프레지던트 101동 2503호
  • 사업자 등록번호 : 106-82-31113
  • 대표자 성명 : 홍은경
  • Tel : 02-714-2428 | Fax : 02-714-5103 | E-mail : endo@endocrinology.or.kr
SNS
instagram facebook twitter